- Home
- Aesthetic gynaecology
- Intimate burning that won't go away
- Recurrent thrush
Recurrent thrush: when the usual treatment is not enough
Does "thrush" come back several times a year? See why it happens, why it is essential to confirm by culture and which induction and maintenance regimen has evidence.
Quando existir, entra aqui e também no cartão da página do blog.
In this article
Itching, burning, redness, thick white discharge. You treat it with a pessary or a tablet, it improves, and a few weeks later it all comes back. For some women, thrush stops being an occasional episode and becomes a problem that recurs several times a year, with a great impact on wellbeing and sex life.
Recurrent thrush is common: it is estimated to affect about 1 in 10 to 1 in 20 women over a lifetime. The good news is that there is a different approach, with more success than repeating short treatments.
Three ideas to remember.
Fica por baixo do resumo, se existir uma segunda foto.
What recurrent thrush is
Vulvovaginal candidiasis is an infection with fungi of the genus Candida, which normally live in the vagina, on the skin and in the gut without causing problems. When they grow in excess or the body reacts disproportionately, symptoms appear.
The definition most widely used today, in European and North American guidelines, is 3 or more symptomatic episodes in 12 months, confirmed by examination. The 2018 European guideline and the 2021 CDC guideline adopted this threshold; older definitions used 4 episodes.
Why it comes back
In most women with recurrent thrush there is no obvious cause. The mechanisms most studied are:
- Altered local immune response: some women have a genetic predisposition to react disproportionately to the presence of Candida.
- Persistence of the fungus: short treatment relieves the symptoms but does not completely eliminate the fungus, which grows back.
- Less sensitive species: about 10% to 20% of recurrent cases are caused by species other than Candida albicans, above all C. glabrata, which respond less well to the usual treatments.
Factors that may contribute
- Poorly controlled diabetes.
- Frequent antibiotics.
- High oestrogen levels: pregnancy, some contraceptives, hormone therapy.
- Immunosuppression (medicines, diseases).
- Some diabetes medicines (SGLT2 inhibitors), which increase glucose in the urine.
- Vaginal douches and irritant products, which alter the flora.
In recurrent thrush, it is worth checking blood glucose, especially if there are other risk factors.
Confirming the diagnosis
This is the most important step, and often skipped. Studies show that a significant proportion of women who self-treat for "thrush" have another cause for their symptoms: bacterial vaginosis, contact dermatitis, lichen sclerosus, vulvodynia or atrophy.
The diagnosis should include:
- Examination of the vulva and vagina.
- Vaginal pH: in thrush it is usually normal (4 to 4.5); if higher, it suggests another cause.
- Microscopy of the discharge.
- Culture with identification of the species, essential in recurrent thrush and, if possible, antifungal sensitivity testing.
Ideally, the sample should be taken while symptomatic and without antifungal treatment in the preceding weeks.
How it is treated
Candida albicans: induction and maintenance
When the culture confirms Candida albicans, the guidelines recommend a two-phase regimen:
- Induction phase:more intensive treatment to control the episode, for example with an oral antifungal in several doses spaced over a few days, or a longer vaginal treatment (7 to 14 days).
- Maintenance phase:one weekly dose of oral antifungal for about 6 months.
In a landmark clinical trial, about 90% of women were symptom-free at 6 months with weekly maintenance, against about 36% without it (Sobel et al., 2004). After stopping, some women have episodes again, and it may be necessary to repeat or prolong maintenance.
Prolonged oral treatment requires medical assessment, consideration of interactions with other medicines and, in some cases, liver function tests. It should not be used during pregnancy, when vaginal treatments are preferred.
When it is another species
Non-albicans species, such as C. glabrata, are often less sensitive to the usual oral antifungals. Treatment is guided by the species and, ideally, by sensitivity testing, and may include boric acid pessaries (compounded in a pharmacy, for vaginal use only) or other specific topical antifungals. Some of these options are used outside the approved indications and should be prescribed by an experienced doctor.
Boric acid is toxic if swallowed. It must be used only vaginally, kept out of the reach of children and avoided in pregnancy.
New options
In recent years, new antifungals specifically studied in recurrent thrush have been approved in other countries. Their availability in Portugal and their place in treatment should be discussed with the doctor.
What has no solid evidence
- Probiotics (oral or vaginal): studies are inconsistent; they can be tried, but they do not replace treatment.
- Sugar-free or "anti-candida" diets: there is no evidence that they prevent recurrences in women without diabetes.
- Treating a partner with no symptoms: studies show no benefit.
- Yoghurt, garlic, tea tree oil or vinegar in the vagina: they can irritate and have no evidence.
- Vaginal douches: they alter the flora and can make things worse.
General measures that help
- Simple hygiene, with only water or a mild soap substitute.
- Avoid scented products, wipes and vaginal douches.
- Cotton underwear; change out of damp clothing quickly.
- Control diabetes, if present.
- Avoid unnecessary antibiotics; if they are needed, talk to the doctor about prevention.
- Treat the skin irritation that remains after flare-ups, with emollients or barrier ointment.
When to see a doctor
Seek prompt assessment if you have fever, pelvic pain, foul-smelling discharge, sores or blisters. In an emergency, call 112. For advice, contact the SNS 24 line (808 24 24 24).
At Luxmed Clinic
At Luxmed Clinic, in Algés, when "thrush" will not go away, we begin by confirming the diagnosis with the appropriate tests, including a culture with identification of the species. From there, we define a treatment and maintenance plan and follow progress, also treating the irritation and fissures that often remain between flare-ups.
Talk to us
The assessment is a conversation, with no obligation. Tell us what concerns you and our team will reply.
This article is for information only and does not replace a medical assessment. Results vary from person to person.
Frequently asked questions
Is thrush a sexually transmitted infection?
No. Candida normally lives in the body. Sexual activity can, in some women, trigger episodes, but it is not considered an STI.
Can I treat myself with over-the-counter pharmacy treatments?
For a typical first episode, it may be reasonable, with the pharmacist's advice. But if episodes recur, it is important to confirm the diagnosis before continuing to treat.
Does my partner need to be treated?
Only if he or she has symptoms. Treating a partner with no symptoms does not reduce recurrences.
After 6 months of maintenance treatment, am I cured?
Many women stay well for a long time; others have episodes again and need a new course or longer maintenance. Follow-up allows adjustments.
Can the pill cause recurrent thrush?
In some women, oestrogen-containing contraceptives may contribute. If you suspect this link, speak to your doctor before changing your contraceptive.
Scientific references 8
- Sobel JD, Wiesenfeld HC, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351(9):876-883. Artigo
- Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15-21. Artigo
- Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2018 European (IUSTI/WHO) International Union against Sexually Transmitted Infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018;29(13):1258-1272. Guideline
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. Guideline
- Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339-e347. Artigo
- Saxon Lead Author GC, Edwards A, Rautemaa-Richardson R, et al. British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis (2019). Int J STD AIDS. 2020;31(12):1124-1144. Guideline
- Ferris DG, Nyirjesy P, Sobel JD, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol. 2002;99(3):419-425. Artigo
- Xie HY, Feng D, Wei DM, et al. Probiotics for vulvovaginal candidiasis in non-pregnant women. Cochrane Database Syst Rev. 2017;11:CD010496. Revisão Cochrane
Keep exploring

